VLA 0.00% $1.75 viralytics limited

Fierce Pharma Research

  1. 1,096 Posts.
    lightbulb Created with Sketch. 5
    An article today on " 2 Potential Boosters for Improving Checkpoint Inhibition in Cancer "
    " Cancer killing viruses are already being used in oncology . Amgen's Inlygic , approved to treat some melanoma patients , is an engineered form of the herpes virus .As a solo treatment it has not been widely effective , but Amgen has been partnered with Merck to test the virus with Keytruda ."

    I have never seen Cavatak or Viralytics mentioned by Fierce Pharma .

    Message to Viralytics : Isn't about time you got onto Fierce Pharma's radar , making them aware that Viralytics has a better drug currently undergoing several trials with outstanding results . Get the PR machine into action .

    Hope they tune into Hot Copper
 
watchlist Created with Sketch. Add VLA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.